IMC welcomes new Chair, Ronnie Miller

Posted on November 21, 2019

Montreal, November 21, 2019–Innovative Medicines Canada is proud to announce that President and CEO of Roche Pharma Canada, Ronnie Miller, has been appointed as Chair of its Board of Directors.

“We are extremely pleased to have Ronnie take on the role of Chair at this critical time for our industry,” said Chair of the Board’s Governance Committee and outgoing Vice Chair John Helou, who announced the appointment at the association’s Annual General Meeting. “A longtime champion for the industry and for the patients who rely on our medicines, Ronnie’s leadership and expertise will help strengthen our association and guide its direction in the coming years.”

Mr. Miller is the President and CEO of Roche Pharma Canada. During his 19 years as head of Roche Canada, Mr. Miller has seen the sector transition from a one-size-fits-all approach to one that is focused on the individual and the delivery of precision medicine.

“Our industry may be facing unprecedented challenges, but I am confident that with a unified voice, we can turn those challenges into opportunities,” said Mr. Miller. “Over the next two years, my focus will be on motivating our industry to continue to work with our stakeholders and partners to help create a healthcare system where innovation thrives, and patients have timely access to the medicines they need.

“By keeping the needs of patients first and foremost in our minds, we will embrace a forward-thinking approach to how we work and ensure that we are looking beyond our immediate challenges to those that lie ahead in the years to come,” he said.

Mr. Miller will serve a two-year term as Chair.

About Innovative Medicines Canada

Innovative Medicines Canada is the national voice of Canada’s innovative pharmaceutical industry. We advocate for policies that enable the discovery, development and commercialization of innovative medicines and vaccines that improve the lives of all Canadians. We support our members’ commitment to being valued partners in the Canadian healthcare system.

– 30 –

For further information:

Sarah Dion-Marquis
Director, Media and Public Relations
Telephone: 613-769-6510
E-mail: sdmarquis@imc-mnc.ca

Leave a Reply

Your email address will not be published. Required fields are marked *